These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 29359676

  • 1. Computational Exploration of Natural Compounds to Target Cytosolic Phospholipase A 2 Protein: A Novel Therapeutic Target for Spinal Cord Injury.
    Fan H, Wang S, Zhao Q, Qin Z.
    Curr Comput Aided Drug Des; 2018; 14(2):117-124. PubMed ID: 29359676
    [Abstract] [Full Text] [Related]

  • 2. Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury.
    Liu NK, Deng LX, Zhang YP, Lu QB, Wang XF, Hu JG, Oakes E, Bonventre JV, Shields CB, Xu XM.
    Ann Neurol; 2014 May; 75(5):644-58. PubMed ID: 24623140
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Cytosolic Phospholipase A2 Has Neuroprotective Effects on Motoneuron and Muscle Atrophy after Spinal Cord Injury.
    Liu NK, Byers JS, Lam T, Lu QB, Sengelaub DR, Xu XM.
    J Neurotrauma; 2021 May 01; 38(9):1327-1337. PubMed ID: 25386720
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats.
    Khan M, Shunmugavel A, Dhammu TS, Matsuda F, Singh AK, Singh I.
    J Neuroinflammation; 2015 May 15; 12():94. PubMed ID: 25971887
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phospholipase A2 superfamily members play divergent roles after spinal cord injury.
    López-Vales R, Ghasemlou N, Redensek A, Kerr BJ, Barbayianni E, Antonopoulou G, Baskakis C, Rathore KI, Constantinou-Kokotou V, Stephens D, Shimizu T, Dennis EA, Kokotos G, David S.
    FASEB J; 2011 Dec 15; 25(12):4240-52. PubMed ID: 21868473
    [Abstract] [Full Text] [Related]

  • 13. DADLE promotes motor function recovery by inhibiting cytosolic phospholipase A2 mediated lysosomal membrane permeabilization after spinal cord injury.
    Chen Y, Zhang H, Jiang L, Cai W, Kuang J, Geng Y, Xu H, Li Y, Yang L, Cai Y, Wang X, Xiao J, Ni W, Zhou K.
    Br J Pharmacol; 2024 Mar 15; 181(5):712-734. PubMed ID: 37766498
    [Abstract] [Full Text] [Related]

  • 14. Discrete roles of intracellular phospholipases A2 in human neutrophil cytotoxicity.
    Mikami S, Aiboshi J, Kobayashi T, Kojima M, Morishita K, Otomo Y.
    J Trauma Acute Care Surg; 2015 Aug 15; 79(2):238-46. PubMed ID: 26218692
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism of glutamine inhibition of cytosolic phospholipase a2 (cPLA2 ): Evidence of physical interaction between glutamine-Induced mitogen-activated protein kinase phosphatase-1 and cPLA2.
    Lee CH, Kim HK, Jeong JS, Lee YD, Jin ZW, Im SY, Lee HK.
    Clin Exp Immunol; 2015 Jun 15; 180(3):571-80. PubMed ID: 25599677
    [Abstract] [Full Text] [Related]

  • 19. A New Generation of Arachidonic Acid Analogues as Potential Neurological Agent Targeting Cytosolic Phospholipase A2.
    Ng CY, Kannan S, Chen YJ, Tan FCK, Ong WY, Go ML, Verma CS, Low CM, Lam Y.
    Sci Rep; 2017 Oct 20; 7(1):13683. PubMed ID: 29057981
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.